| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/30/2013 | CN102895297A Preparation technology and production method for integrated new formulation of radix stephaniae tetrandrae and radix astragali decoction |
| 01/30/2013 | CN102895244A Pharmaceutical composition |
| 01/30/2013 | CN102895243A Application of Gypensapogenin B to medicament for increasing erythrocytes |
| 01/30/2013 | CN102895204A Sevelamer carbonate crude drug for preparing tablets, preparation method and application thereof |
| 01/30/2013 | CN102895200A Mecobalamine freeze-drying composition and preparation method thereof |
| 01/30/2013 | CN102895179A Argatroban formulation comprising an acid as solubilizer |
| 01/30/2013 | CN102337190B Method for making honey health-care wine |
| 01/30/2013 | CN102091081B Composition for preventing or treating apoplexy and application thereof |
| 01/30/2013 | CN102051321B Red jujube health-care liquor and production process thereof |
| 01/30/2013 | CN102000124B Ginkgo biloba extract oral liquid and preparation method thereof |
| 01/30/2013 | CN101947315B Application of Chinese medicinal bitter apricot seeds in lysozyme sodium alginate microspheres |
| 01/30/2013 | CN101896477B The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof |
| 01/30/2013 | CN101879165B Novel antihypertensive medicament compound preparation |
| 01/30/2013 | CN101849907B Nanoemulsion of N-[4-(2,4 dimethoxy phenyl)-5-oxygroup-4,5-dihydro-[1,2] disulfide group-[4,3-b]-6-pyrryl]-3,5-di-trifluoromethyl benzamide and preparation method thereof |
| 01/30/2013 | CN101669624B Chinese medicinal assorted Chinese herbal tea with function of improving woman anemia and preparation method thereof |
| 01/30/2013 | CN101189023B 监测和调制hgf/hgfr活性 Monitoring and modulation hgf / hgfr activity |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | CA2507987C A vegetable composition having blood enhancing properties |
| 01/29/2013 | CA2469310C Plasmid mediated supplementation for treating chronically ill subjects |
| 01/24/2013 | WO2013013228A1 Methods for determining patient response to anti-platelet aggregation therapy |
| 01/24/2013 | WO2013011238A1 Novel haemostatic composition |
| 01/24/2013 | WO2013010502A1 Acid addition salt of prasugrel, preparation method therefor and use thereof |
| 01/24/2013 | WO2013010380A1 Btk inhibitors |
| 01/24/2013 | US20130024960 Optimised coding sequence and promoter |
| 01/24/2013 | US20130023584 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023583 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023572 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
| 01/24/2013 | US20130023563 Amidinoaniline derivative |
| 01/24/2013 | US20130023559 Alcohol free formulation of argatroban |
| 01/24/2013 | US20130023543 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023524 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 01/24/2013 | US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 01/24/2013 | US20130023520 Anaesthetic eye solution and method of use |
| 01/24/2013 | US20130023517 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 01/24/2013 | US20130023509 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023508 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023507 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023506 Method for treating uterine fibroids |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023478 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 01/24/2013 | US20130022683 Method for improving dissolution of anticoagulant agent |
| 01/24/2013 | US20130022671 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022634 New composition and methods for treatment of autoimmune and allergic diseases |
| 01/24/2013 | US20130022622 Compounds for the treatment of autism |
| 01/24/2013 | US20130022610 Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130022582 Multipotent nestin-positive cells |
| 01/24/2013 | US20130022581 Placental stem cell populations |
| 01/24/2013 | US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
| 01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 01/24/2013 | CA2842682A1 Methods for determining patient response to anti-platelet aggregation therapy |
| 01/24/2013 | CA2841899A1 Btk inhibitors |
| 01/23/2013 | EP2548880A2 Compositions for increasing telomerase activity |
| 01/23/2013 | EP2548879A1 Crystal of diamine derivative and method of producing same |
| 01/23/2013 | EP2548872A1 Cyclopropanecarboxylic acid derivative |
| 01/23/2013 | EP2548871A1 Cycloalkyl-substituted imidazole derivative |
| 01/23/2013 | EP2548561A1 Semuloparin for improving the survival of patients with locally advanced cancer |
| 01/23/2013 | EP2548556A1 Method for improving dissolvability of anticoagulant |
| 01/23/2013 | EP2547344A1 Esterified polysaccharide osmotic agents |
| 01/23/2013 | CN202682011U Medical bleeding stopping emergency treatment belt |
| 01/23/2013 | CN1919339B Cucurbitacin nano preparation comprising protein, preparation method and use thereof |
| 01/23/2013 | CN102892415A Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias |
| 01/23/2013 | CN102888279A Extracting method of corn stigma essential oil |
| 01/23/2013 | CN102887962A Method for preparing green tea polysaccharide through separation and purification and application of polysaccharide |
| 01/23/2013 | CN102887941A PAK (polyester alkyd)/ imidazoline/RGD (arginine-glycine-aspartic acid) ternary conjugate and preparation method and use thereof |
| 01/23/2013 | CN102886052A Long lasting drug formulations |
| 01/23/2013 | CN102885998A Medicine composition for preventing or treating bone marrow suppression caused by tumor radiotherapy |
| 01/23/2013 | CN102885950A Pharmaceutical composition for treating cervix uteri postoperative bleeding |
| 01/23/2013 | CN102885936A Blood replenishing oral liquid and preparation method thereof |
| 01/23/2013 | CN102885925A Chinese medicinal preparation for treating deficiency of qi and blood, qi stagnation and blood stasis |
| 01/23/2013 | CN102885908A Medicament for treating aplastic anemia |
| 01/23/2013 | CN102885896A Medicine for treating thromboangitis obliterans |
| 01/23/2013 | CN102885780A Method for improving bioavailability of resveratrol |
| 01/23/2013 | CN102885774A Prasugrel composition and preparation method thereof |
| 01/23/2013 | CN102579349B Torasemide liposome injection |
| 01/23/2013 | CN102397253B Clopidogrel bisulfate liposome solid preparation |
| 01/23/2013 | CN102247420B Preparation method and application of eclipta extract |
| 01/23/2013 | CN102204949B Method for preparing dalbergia odorifera seed extract and dalbergia odorifera seed extract |
| 01/23/2013 | CN102199615B cDNA sequence coding fibrinolysin, amino acid sequence and applications of sequences |
| 01/23/2013 | CN101816701B Process for preparing kudzu root extract instant grains |
| 01/23/2013 | CN101791309B Oral solid preparation containing clopidogrel hydrogen sulfate |
| 01/23/2013 | CN101703690B Medicament for treating metrorrhagia and metrostaxis, hematemesis, hematochezia and traumatic hemorrhage and preparation method thereof |
| 01/23/2013 | CN101641112B A novel combination of epimedium-derived-flavonoids-fractions for prevention of steroid-induced osteonecrosis |
| 01/23/2013 | CN101530465B Total salvianolic acid and Panax notoginsenosides and application of mixture thereof in treatment of septicemia |
| 01/23/2013 | CN101486715B Novel oxazine compound and use for preventing platelet aggregation |
| 01/23/2013 | CN101210244B Neutrokine-alpha and Neutrokine-alpha splice variants |
| 01/22/2013 | US8357674 Analogues of cilostazol |
| 01/22/2013 | US8357370 Anti-D monoclonal antibodies |
| 01/22/2013 | CA2588979C 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 01/22/2013 | CA2537250C Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 01/22/2013 | CA2343716C Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/22/2013 | CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 01/17/2013 | WO2013008100A1 Methods for the treatment and prevention of thrombosis |
| 01/17/2013 | WO2013008099A1 Antibodies for the treatment and prevention of thrombosis |
| 01/17/2013 | WO2013008098A1 Antibodies for the treatment and prevention of thrombosis |
| 01/17/2013 | WO2013007762A1 Combination of an anticoagulant and avidin useful in surgical intervention and clinical procedure |
| 01/17/2013 | WO2013006906A1 Dermatan sulphate, pharmaceutical compositions and process for producing same |